Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on
POSTS IN CATEGORY
SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) — Risen Pharma, a clinical-stage biotech company focusing on
SINGAPORE, May 19, 2026 (GLOBE NEWSWIRE) — Jenfi, a Southeast Asia-focused SME credit platform, today
Milestone Move to IMS on AWS Achieved as Operator Transitions Fixed and Mobile Subscriber Base
Ahead of Russian President Vladimir Putin’s visit to China from May 19 to 20, CGTN